Inc

BioXcel Therapeutics sNDA submission expected in early Q1 2026 for expanded usage of IGALMI® in home setting based…

Retirement saving requires key decisions: when to start, how much to save, and where to invest. The investing…

Data demonstrates proof -of-mechanism for In Vivo CAR therapy in solid tumors CAMBRIDGE, Mass., Nov. 7, 2025 /PRNewswire/…

COPENHAGEN, Denmark (AP) — In 2021, Danish video game live-streamer Marie Watson received an image of herself from…

Google Maps is heading in a new direction with artificial intelligence sitting in the passenger’s seat. Fueled by…

SANDPOINT, Idaho, Nov. 05, 2025 (GLOBE NEWSWIRE) — Kochava, the leading real-time data solutions company for omnichannel outcomes,…

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a…

Microsoft has entered into a $9.7 billion cloud services contract with artificial intelligence cloud service provider IREN that…

WASHINGTON (AP) — The head of the Food and Drug Administration’s drug center abruptly resigned Sunday after federal…

SEOUL, South Korea (AP) — Lee Soo Man resisted the title at first. “King of K-pop” sounded too…

Nebius Group N.V. NBIS and Amazon.com, Inc. AMZN are major players in the rapidly expanding AI cloud infrastructure…

A Landmark Regulatory Shift Validates Professor Sarfaraz K. Niazi’s Vision to Make Biologics as Affordable as Generics CHICAGO,…

BioXcel Therapeutics Reports Third Quarter 2025 Financial Results and Provides Update on Late-Stage Clinical Programs for Agitation in Bipolar, Schizophrenia, and Alzheimer’s Disease